Catalog Home Page

Publications: Riley, Thomas

Stats for Riley, Thomas
Export as [feed] RSS
Group by: Publication Type | Year
Number of items: 273.

Journal Article

Tague, A.J., Putsathit, P., Hammer, K.A., Wales, S.M., Knight, D.R., Riley, T.V., Keller, P.A. and Pyne, S.G. (2019) Cationic biaryl 1,2,3-triazolyl peptidomimetic amphiphiles: Synthesis, antibacterial evaluation and preliminary mechanism of action studies. European Journal of Medicinal Chemistry . In Press.

Carter, G.P., Harjani, J.R., Liu, L., Pitcher, N.P., Nong, Y., Riley, T.V., Williamson, D.A., Stinear, T.P., Baell, J.B. and Howden, B.P. (2018) 1,2,4-Oxadiazole antimicrobials act synergistically with daptomycin and display rapid kill kinetics against MDR Enterococcus faecium. Journal of Antimicrobial Chemotherapy, 73 (6). pp. 1562-1569.

Androga, G.O., Knight, D.R., Lim, S.C., Foster, N.F. and Riley, T.V. (2018) Antimicrobial resistance in large clostridial toxin-negative, binary toxin-positive Clostridium difficile ribotypes. Anaerobe, 54 . pp. 55-60.

Lim, S-C, Androga, G.O., Knight, D.R., Moono, P., Foster, N.F. and Riley, T.V. (2018) Antimicrobial susceptibility of Clostridium difficile isolated from food and environmental sources in Western Australia. International Journal of Antimicrobial Agents, 52 (3). pp. 411-415.

Collins, D.A. and Riley, T.V. (2018) Clostridium difficile guidelines. Clinical Infectious Diseases, 67 (10). p. 1639.

Mulrennan, S., Tai, A., Eng, L., Putsathit, P., Collins, D. and Riley, T. (2018) Clostridium difficile infection in cystic fibrosis patients. Pediatric Pulmonology, 53 (S2). S393-S393.

Larcombe, S., Hutton, M.L., Riley, T.V., Abud, H.E. and Lyras, D. (2018) Diverse bacterial species contribute to antibiotic-associated diarrhoea and gastrointestinal damage. Journal of Infection, 77 (5). pp. 417-426.

Roshan, N., Riley, T.V., Knight, D.R. and Hammer, K.A. (2018) Effect of natural products on the production and activity of Clostridium difficile toxins in vitro. Scientific Reports, 8 (1). article 15735.

Roshan, N., Riley, T.V. and Hammer, K.A. (2018) Effects of natural products on several stages of the spore cycle of Clostridium difficile in vitro. Journal of Applied Microbiology, 125 (3). pp. 710-723.

Riley, T.V. and Kimura, T. (2018) The Epidemiology of Clostridium difficile Infection in Japan: A Systematic Review. Infectious Diseases and Therapy, 7 (1). pp. 39-70.

McGovern, A.M., Androga, G.O., Moono, P., Collins, D.A., Foster, N.F., Chang, B.J. and Riley, T.V. (2018) Evaluation of the Cepheid ® Xpert ® C. difficile binary toxin (BT) diagnostic assay. Anaerobe, 51 . pp. 12-16.

Lim, S.C., Foster, N.F., Elliott, B. and Riley, T.V. (2018) High prevalence of Clostridium difficile on retail root vegetables, Western Australia. Journal of Applied Microbiology, 124 (2). pp. 585-590.

Riley, T.V., Collins, D.A., Karunakaran, R., Kahar, M.A., Adnan, A., Hassan, S.A., Zainul, N.H., Rustam, F.R.M., Wahab, Z.A., Ramli, R., Lee, Y.Y., Hassan, H. and Onderdonk, A.B. (2018) High prevalence of toxigenic and nontoxigenic clostridium difficile strains in Malaysia. Journal of Clinical Microbiology, 56 (6).

Amy, J., Bulach, D., Knight, D., Riley, T., Johanesen, P. and Lyras, D. (2018) Identification of large cryptic plasmids in Clostridioides ( Clostridium ) difficile. Plasmid, 96-97 . pp. 25-38.

Roshan, N., Hammer, K.A. and Riley, T.V. (2018) Non-conventional antimicrobial and alternative therapies for the treatment of Clostridium difficile infection. Anaerobe, 49 . pp. 103-111.

Wehrhahn, M.C., Keighley, C., Kurtovic, J., Knight, D.R., Hong, S., Hutton, M.L., Lyras, D., Wang, Q., Leong, R., Borody, T., Edye, M. and Riley, T.V. (2018) A series of three cases of severe Clostridium difficile infection in Australia associated with a binary toxin producing clade 2 ribotype 251 strain. Anaerobe . In Press.

Roshan, N., Riley, T.V. and Hammer, K.A. (2017) Antimicrobial activity of natural products against Clostridium difficile in vitro. Journal of Applied Microbiology, 123 (1). pp. 92-103.

Cheong, E., Roberts, T., Rattanavong, S., Riley, T.V., Newton, P.N. and Dance, D.A.B. (2017) Clostridium difficile infection in the Lao People’s Democratic Republic: first isolation and review of the literature. BMC Infectious Diseases, 17 (1).

Elliott, B., Androga, G.O., Knight, D.R. and Riley, T.V. (2017) Clostridium difficile infection: Evolution, phylogeny and molecular epidemiology. Infection, Genetics and Evolution, 49 . pp. 1-11.

Knight, D.R., Squire, M.M., Collins, D.A. and Riley, T.V. (2017) Genome analysis of Clostridium difficile PCR ribotype 014 lineage in Australian pigs and humans reveals a diverse genetic repertoire and signatures of long-range interspecies transmission. Frontiers in Microbiology, 7 .

Moono, P., Lim, S.C. and Riley, T.V. (2017) High prevalence of toxigenic Clostridium difficile in public space lawns in Western Australia. Scientific Reports, 7 . Article 41196.

Zainul, N.H, Ma, Z.F., Besari, A., Siti Asma, H., Rahman, R.A., Collins, D.A., Hamid, N., Riley, T.V. and Lee, Y.Y. (2017) Prevalence of Clostridium difficile infection and colonization in a tertiary hospital and elderly community of North-Eastern Peninsular Malaysia. Epidemiology and Infection, 145 (14). pp. 3012-3019.

McGovern, A.M., Androga, G.O., Knight, D.R., Watson, M.W., Elliott, B., Foster, N.F., Chang, B.J. and Riley, T.V. (2017) Prevalence of binary toxin positive Clostridium difficile in diarrhoeal humans in the absence of epidemic ribotype 027. PLoS ONE, 12 (11). e0187658.

Trubiano, J.A., Cheng, A.C., Korman, T.M., Roder, C., Campbell, A., May, M.L.A., Blyth, C.C., Ferguson, J.K., Blackmore, T.K., Riley, T.V. and Athan, E. (2016) Australasian Society of Infectious Diseases updated guidelines for the management of Clostridium difficile infection in adults and children in Australia and New Zealand. Internal Medicine Journal, 46 (4). pp. 479-493.

Moono, P., Foster, N.F., Hampson, D.J., Knight, D.R., Bloomfield, L.E. and Riley, T.V. (2016) Clostridium difficile infection in production animals and Avian species: A review. Foodborne Pathogens and Disease, 13 (12). pp. 647-655.

Selvey, L.A., Slimings, C., Joske, D.J.L. and Riley, T.V. (2016) Clostridium difficile infections amongst patients with haematological malignancies: A data linkage study. PLoS ONE, 11 (6). e0157839.

Burnham, C-A.D., Dubberke, E.R., Kociolek, L.K., Polage, C.R. and Riley, T.V. (2016) Clostridium difficile-Diagnostic and clinical challenges. Clinical Chemistry, 62 (2). pp. 310-314.

Knight, D.R. and Riley, T.V. (2016) Clostridium difficileclade 5 in Australia: antimicrobial susceptibility profiling of PCR ribotypes of human and animal origin. Journal of Antimicrobial Chemotherapy, 71 (8). pp. 2213-2217.

Carson, K.C. and Riley, T.V. (2016) Comparison of the Vidas C. difficile and Quik Chek-60 glutamate dehydrogenase assays for the detection of Clostridium difficile in faecal samples. Pathology, 48 (5). pp. 506-508.

Knight, D.R., Putsathit, P., Elliott, B. and Riley, T.V. (2016) Contamination of Australian newborn calf carcasses at slaughter with Clostridium difficile. Clinical Microbiology and Infection, 22 (3). 266.e1-266.e7.

Bloomfield, L.E. and Riley, T.V. (2016) Epidemiology and risk factors for community-associated clostridium difficile infection: A narrative review. Infectious Diseases and Therapy, 5 (3). pp. 231-251.

Cheng, A.C., Collins, D.A., Elliott, B., Ferguson, J.K., Paterson, D.L., Thean, S. and Riley, T.V. (2016) Laboratory-based surveillance of Clostridium difficile circulating in Australia, September – November 2010. Pathology, 48 (3). pp. 257-260.

Moono, P., Putsathit, P., Knight, D.R., Squire, M.M., Hampson, D.J., Foster, N.F. and Riley, T.V. (2016) Persistence of Clostridium difficile RT 237 infection in a Western Australian piggery. Anaerobe, 37 . pp. 62-66.

Hall, L., Farrington, A., Mitchell, B.G., Barnett, A.G., Halton, K., Allen, M., Page, K., Gardner, A., Havers, S., Bailey, E., Dancer, S.J., Riley, T.V., Gericke, C.A., Paterson, D.L. and Graves, N. (2016) Researching effective approaches to cleaning in hospitals: protocol of the REACH study, a multi-site stepped-wedge randomised trial. Implementation Science, 11 (1). Article number 44.

Collins, D.A. and Riley, T.V. (2016) Routine detection of Clostridium difficile in Western Australia. Anaerobe, 37 . pp. 34-37.

Lim, S-C, Foster, N.F. and Riley, T.V. (2016) Susceptibility of Clostridium difficile to the food preservatives sodium nitrite, sodium nitrate and sodium metabisulphite. Anaerobe, 37 . pp. 67-71.

Malhi, H.K., Tu, J., Riley, T.V., Kumarasinghe, S.P. and Hammer, K.A. (2016) Tea tree oil gel for mild to moderate acne; a 12 week uncontrolled, open-label phase II pilot study. Australasian Journal of Dermatology, In press .

Knight, D.R., Androga, G.O., Ballard, S.A., Howden, B.P. and Riley, T.V. (2016) A phenotypically silent vanB2 operon carried on a Tn1549-like element in Clostridium difficile. mSphere, 1 (4). e00177-16.

Tracey, L., Kirke, A., Armstrong, P. and Riley, T.V. (2015) From the hospital to the home--the rise and rise of Clostridium difficile infection. Australian Family Physician, 44 (10). pp. 712-7.

Furuya-Kanamori, L., Marquess, J., Yakob, L., Riley, T.V., Paterson, D.L., Foster, N.F., Huber, C.A. and Clements, A.C.A. (2015) Asymptomatic Clostridium difficile colonization: epidemiology and clinical implications. BMC Infectious Diseases, 15 (1).

Wales, S.M., Hammer, K.A., King, A.M., Tague, A.J., Lyras, D., Riley, T.V., Keller, P.A. and Pyne, S.G. (2015) Binaphthyl-1,2,3-triazole peptidomimetics with activity against Clostridium difficile and other pathogenic bacteria. Organic & Biomolecular Chemistry, 13 (20). pp. 5743-5756.

Putsathit, P., Kiratisin, P., Ngamwongsatit, P. and Riley, T.V. (2015) Clostridium difficile infection in Thailand. International Journal of Antimicrobial Agents, 45 (1). pp. 1-7.

Furuya-Kanamori, L., McKenzie, S.J., Yakob, L., Clark, J., Paterson, D.L., Riley, T.V. and Clements, A.C. (2015) Clostridium difficile infection seasonality: Patterns across hemispheres and continents - A systematic review. PLoS ONE, 10 (3). Article e0120730.

Furuya-Kanamori, L., Stone, J.C., Clark, J., McKenzie, S.J., Yakob, L., Paterson, D.L., Riley, T.V., Doi, S.A.R. and Clements, A.C. (2015) Comorbidities, exposure to medications, and the risk of community-acquired clostridium difficile infection: A systematic review and meta-analysis. Infection Control & Hospital Epidemiology, 36 (02). pp. 132-141.

Knight, D.R., Elliott, B., Chang, B.J., Perkins, T.T. and Riley, T.V. (2015) Diversity and evolution in the genome of clostridium difficile. Clinical Microbiology Reviews, 28 (3). pp. 721-741.

Eyre, D.W., Tracey, L., Elliott, B., Slimings, C., Huntington, P.G., Stuart, R.L., Korman, T.M., Kotsiou, G., McCann, R., Griffiths, D., Fawley, W.N., Armstrong, P., Dingle, K.E., Walker, A.S., Peto, T.E., Crook, D.W., Wilcox, M.H. and Riley, T.V. (2015) Emergence and spread of predominantly community-onset Clostridium difficile PCR ribotype 244 infection in Australia, 2010 to 2012. Eurosurveillance, 20 (10). Article 21059.

Putsathit, P., Morgan, J., Bradford, D., Engelhardt, N. and Riley, T.V. (2015) Evaluation of the BD Max Cdiff assay for the detection of toxigenic Clostridium difficile in human stool specimens. Pathology, 47 (2). pp. 165-168.

Androga, G.O., McGovern, A.M., Elliott, B., Chang, B.J., Perkins, T.T., Foster, N.F., Riley, T.V. and Onderdonk, A.B. (2015) Evaluation of the Cepheid Xpert C. difficile/Epi and meridian bioscience illumigene C. difficile assays for detecting Clostridium difficile ribotype 033 strains. Journal of Clinical Microbiology, 53 (3). pp. 973-975.

Chong, R.S-M, Shinwari, M.W., Amigh, M.J., Aravena-Roman, M and Riley, T.V. (2015) First report of Erysipelothrix rhusiopathiae-associated septicaemia and histologic changes in cultured Australian eels, Anguilla reinhardtii (Steindachner, 1867) and A. australis (Richardson, 1841). Journal of Fish Diseases, 38 (9). pp. 839-847.

Mori, N., Yoshizawa, S., Saga, T., Ishii, Y., Murakami, H., Iwata, M., Collins, D.A., Riley, T.V. and Tateda, K. (2015) Incorrect diagnosis of Clostridium difficile infection in a university hospital in Japan. Journal of Infection and Chemotherapy, 21 (10). pp. 718-722.

Androga, G.O., Hart, J., Foster, N.F., Charles, A., Forbes, D., Riley, T.V. and Land, G.A. (2015) Infection with toxin a-negative, toxin b-negative, binary toxin-positive clostridium difficile in a young patient with ulcerative colitis. Journal of Clinical Microbiology, 53 (11). pp. 3702-3704.

Yakob, L., Riley, T.V., Paterson, D.L., Marquess, J., Magalhaes, R.J.S., Furuya-Kanamori, L. and Clements, A.C.A. (2015) Mechanisms of hypervirulent Clostridium difficile ribotype 027 displacement of endemic strains: an epidemiological model. Scientific Reports, 5 . Article 12666.

Mackin, K.E., Elliott, B., Kotsanas, D., Howden, B.P., Carter, G.P., Korman, T.M., Riley, T.V., Rood, J.I., Jenkin, G.A. and Lyras, D. (2015) Molecular characterization and antimicrobial susceptibilities of Clostridium difficile clinical isolates from Victoria, Australia. Anaerobe, 34 . pp. 80-83.

Ngamskulrungroj, P., Sanmee, S., Pusathit, P., Piewngam, P., Elliott, B., Riley, T.V. and Kiratisin, P. (2015) Molecular epidemiology of Clostridium difficile infection in a large teaching hospital in Thailand. PLoS ONE, 10 (5). Article e0127026.

Collins, D.A., Elliott, B. and Riley, T.V. (2015) Molecular methods for detecting and typing of Clostridium difficile. Pathology, 47 (3). pp. 211-218.

Knight, D.R., Squire, M.M., Riley, T.V. and Björkroth, J. (2015) Nationwide surveillance study of Clostridium difficile in Australian neonatal pigs shows high prevalence and heterogeneity of PCR ribotypes. Applied and Environmental Microbiology, 81 (1). pp. 119-123.

Knight, D.R., Giglio, S., Huntington, P.G., Korman, T.M., Kotsanas, D., Moore, C.V., Paterson, D.L., Prendergast, L., Huber, C.A., Robson, J., Waring, L., Wehrhahn, M.C., Weldhagen, G.F., Wilson, R.M. and Riley, T.V. (2015) Surveillance for antimicrobial resistance in Australian isolates of Clostridium difficile, 2013–14. Journal of Antimicrobial Chemotherapy, 70 (11). pp. 2992-2999.

Wales, S.M., Hammer, K.A., Somphol, K., Kemker, I., Schröder, D.C., Tague, A.J., Brkic, Z., King, A.M., Lyras, D., Riley, T.V., Bremner, J.B., Keller, P.A. and Pyne, S.G. (2015) Synthesis and antimicrobial activity of binaphthyl-based, functionalized oxazole and thiazole peptidomimetics. Organic and Biomolecular Chemistry, 13 (44). pp. 10813-10824.

Jennepalli, S., Hammer, K.A., Riley, T.V., Pyne, S.G. and Keller, P.A. (2015) Synthesis of mono and Bis[60]fullerene-based dicationic peptoids. European Journal of Organic Chemistry, 2015 (1). pp. 195-201.

Knight, D.R, Riley, T.V., Crook, D.W, Gottardo, N.G, Hart, J. and Eyre, D.W (2015) Two cases of Clostridium difficile infection in unrelated oncology patients attributable to a single clone of C. difficile PCR ribotype 126. JMM Case Reports, 2 (3).

Huber, C.A., Hall, L., Foster, N.F., Gray, M., Allen, M., Richardson, L.J, Robson, J., Vohra, R., Schlebusch, S., George, N., Nimmo, G.R, Riley, T.V. and Paterson, D.L (2014) Surveillance snapshot of Clostridium difficile infection in hospitals across Queensland detects binary toxin producing ribotype UK 244. Communicable diseases intelligence quarterly report, 38 (4). E279-84.

Slimings, C. and Riley, T.V. (2014) Antibiotics and hospital-acquired Clostridium difficile infection: update of systematic review and meta-analysis. Journal of Antimicrobial Chemotherapy, 69 (4). pp. 881-891.

Yakob, L., Riley, T.V., Paterson, D.L, Marquess, J. and Clements, A.C.A. (2014) Assessing control bundles for Clostridium difficile: a review and mathematical model. Emerging Microbes & Infections, 3 (6). e43.

Hart, J., Putsathit, P., Knight, D.R., Sammels, L., Riley, T.V. and Keil, A. (2014) Clostridium difficile infection diagnosis in a paediatric population: comparison of methodologies. European Journal of Clinical Microbiology & Infectious Diseases, 33 (9). pp. 1555-1564.

Aravena-Román, M., Inglis, T.J.J., Riley, T.V. and Chang, B.J. (2014) Distribution of 13 virulence genes among clinical and environmental Aeromonas spp. in Western Australia. European Journal of Clinical Microbiology & Infectious Diseases, 33 (11). pp. 1889-1895.

Pickering, J., Smith-Vaughan, H., Beissbarth, J., Bowman, J.M., Wiertsema, S., Riley, T.V., Leach, A. J., Richmond, P., Lehmann, D. and Kirkham, L- A. (2014) Diversity of Nontypeable Haemophilus influenzae strains colonizing Australian Aboriginal and non-Aboriginal children. Journal of Clinical Microbiology, 52 (5). pp. 1352-1357.

Lim, S.K., Stuart, R.L., Mackin, K.E., Carter, G.P., Kotsanas, D., Francis, M.J., Easton, M., Dimovski, K., Elliott, B., Riley, T.V., Hogg, G., Paul, E., Korman, T.M., Seemann, T., Stinear, T.P., Lyras, D. and Jenkin, G.A. (2014) Emergence of a ribotype 244 strain of clostridium difficile associated with severe disease and related to the epidemic ribotype 027 strain. Clinical Infectious Diseases, 58 (12). pp. 1723-1730.

Foster, N.F., Collins, D.A., Ditchburn, S.L., Duncan, C.N., van Schalkwyk, J.W., Golledge, C.L., Keed, A.B.R. and Riley, T.V. (2014) Epidemiology of Clostridium difficile infection in two tertiary-care hospitals in Perth, Western Australia: a cross-sectional study. New Microbes and New Infections, 2 (3). pp. 64-71.

Dingle, K.E., Elliott, B., Robinson, E., Griffiths, D., Eyre, D.W., Stoesser, N., Vaughan, A., Golubchik, T., Fawley, W.N., Wilcox, M.H., Peto, T.E., Walker, A.S., Riley, T.V., Crook, D.W. and Didelot, X. (2014) Evolutionary history of the Clostridium difficile pathogenicity locus. Genome Biology and Evolution, 6 (1). pp. 36-52.

Slimings, C., Armstrong, P., Beckingham, W.D., Bull, A.L., Hall, L., Kennedy, K.J., Marquess, J., McCann, R., Menzies, A., Mitchell, B.G., Richards, M.J., Smollen, P.C., Tracey, L., Wilkinson, I.J., Wilson, F.L., Worth, L.J. and Riley, T.V. (2014) Increasing incidence of Clostridium difficile infection, Australia, 2011–2012. The Medical Journal of Australia, 200 (5). pp. 272-276.

Manzo, C.E., Merrigan, M.M., Johnson, S., Gerding, D.N., Riley, T.V., Silva, J. and Brazier, J.S. (2014) International typing study of Clostridium difficile. Anaerobe, 28 . pp. 4-7.

Knight, D.R., Squire, M.M. and Riley, T.V. (2014) Laboratory detection of Clostridium difficile in piglets in Australia. Journal of Clinical Microbiology, 52 (11). pp. 3856-3862.

Lee, J-H, Lee, Y., Lee, K., Riley, T.V. and Kim, H. (2014) The changes of PCR ribotype and antimicrobial resistance of Clostridium difficile in a tertiary care hospital over 10 years. Journal of Medical Microbiology, 63 (6). pp. 819-823.

Elliott, B., Dingle, K.E., Didelot, X., Crook, D.W. and Riley, T.V. (2014) The complexity and diversity of the pathogenicity locus in Clostridium difficile clade 5. Genome Biology and Evolution, 6 (12). pp. 3159-3170.

Tan, X.Q., Verrall, A.J., Jureen, R., Riley, T.V., Collins, D.A., Lin, R.T., Balm, M.N., Chan, D. and Tambyah, P.A. (2014) The emergence of community-onset Clostridium difficile infection in a tertiary hospital in Singapore: A cause for concern. International Journal of Antimicrobial Agents, 43 (1). pp. 47-51.

Furuya-Kanamori, L., Robson, J., Soares Magalhães, R.J., Yakob, L., McKenzie, S.J., Paterson, D. L., Riley, T.V. and Clements, A.C.A. (2014) A population-based spatio-temporal analysis of Clostridium difficile infection in Queensland, Australia over a 10-year period. Journal of Infection, 69 (5). pp. 447-455.

Duncan, C.N., Riley, T.V., Carson, K.C., Budgeon, C.A. and Siffleet, J. (2013) The effect of an acidic cleanser versus soap on the skin pH and micro-flora of adult patients: a non-randomised two group crossover study in an intensive care unit. Intensive & Critical Care Nursing, 29 (5). pp. 291-296.

Aravena-Roman, M., Beaz-Hidalgo, R., Inglis, T.J.J., Riley, T.V., Martinez-Murcia, A.J., Chang, B.J. and Figueras, M.J. (2013) Aeromonas australiensis sp. nov., isolated from irrigation water. International Journal of Systematic and Evolutionary Microbiology, 63 (Pt 6). pp. 2270-2276.

Huber, C.A., Foster, N.F., Riley, T.V. and Paterson, D.L. (2013) Challenges for standardization of Clostridium difficile typing methods. Journal of Clinical Microbiology, 51 (9). pp. 2810-2814.

Yakob, L., Riley, T.V., Paterson, D.L. and Clements, A.C.A. (2013) Clostridium difficile exposure as an insidious source of infection in healthcare settings: an epidemiological model. BMC Infectious Diseases, 13 (1).

Boseiwaqa, L.V., Foster, N.F., Thean, S.K., Squire, M.M., Riley, T.V. and Carson, K.C. (2013) Comparison of ChromID C. difficile agar and cycloserine-cefoxitin-fructose agar for the recovery of Clostridium difficile. Pathology, 45 (5). pp. 495-500.

Knight, D.R., Thean, S., Putsathit, P., Fenwick, S. and Riley, T.V. (2013) Cross-sectional study reveals high prevalence of Clostridium difficile Non-PCR ribotype 078 strains in Australian veal calves at slaughter. Applied and Environmental Microbiology, 79 (8). pp. 2630-2635.

Thomsen, N.A., Hammer, K.A., Riley, T.V., Van Belkum, A. and Carson, C.F. (2013) Effect of habituation to tea tree (Melaleuca alternifolia) oil on the subsequent susceptibility of Staphylococcus spp. to antimicrobials, triclosan, tea tree oil, terpinen-4-ol and carvacrol. International Journal of Antimicrobial Agents, 41 (4). pp. 343-351.

Collins, D.A, Hawkey, P.M and Riley, T.V. (2013) Epidemiology of Clostridium difficile infection in Asia. Antimicrobial Resistance and Infection Control, 2 (1).

Vaughan-Higgins, R.J., Bradfield, K., Friend, J.A., Riley, T.V. and Vitali, S.D. (2013) Erysipelas in a numbat (myrmecobius fasciatus). Journal of Zoo and Wildlife Medicine, 44 (1). pp. 208-211.

Boulos, R.A., Man, N.Y.T., Lengkeek, N.A., Hammer, K.A., Foster, N.F., Stemberger, N.A., Skelton, B.W., Wong, P.Y., Martinac, B., Riley, T.V., McKinley, A.J. and Stewart, S.G. (2013) Inspiration from old dyes: Tris(stilbene) compounds as potent gram-positive antibacterial agents. Chemistry - A European Journal, 19 (52). pp. 17980-17988.

Carson, K.C., Boseiwaqa, L.V., Thean, S.K., Foster, N.F. and Riley, T.V. (2013) Isolation of Clostridium difficile from faecal specimens - a comparison of chromID C. difficile agar and cycloserine-cefoxitin-fructose agar. Journal of Medical Microbiology, 62 (Pt_9). pp. 1423-1427.

Squire, M.M., Carter, G.P., Mackin, K.E., Chakravorty, A., Norén, T., Elliott, B., Lyras, D. and Riley, T.V. (2013) Novel molecular type of clostridium difficile in neonatal pigs, Western Australia. Emerging Infectious Diseases, 19 (5).

Goh, S., Hussain, H., Chang, B.J., Emmett, W., Riley, T.V. and Mullany, P. (2013) Phage ϕC2 mediates transduction of Tn6215, encoding erythromycin resistance, between Clostridium difficile strains. mBio, 4 (6). e00840.

Friedman, N.D., Pollard, J., Stupart, D., Knight, D.R, Khajehnoori, M., Davey, E.K, Parry, L. and Riley, T.V. (2013) Prevalence of Clostridium difficile colonization among healthcare workers. BMC Infectious Diseases, 13 (1).

Knight, D.R. and Riley, T.V. (2013) Prevalence of gastrointestinal clostridium difficile carriage in australian sheep and lambs. Applied and Environmental Microbiology, 79 (18). pp. 5689-5692.

de Almeida, M.N., Heffernan, H., Dervan, A., Bakker, S., Freeman, J.T., Bhally, H., Taylor, S.L., Riley, T.V. and Roberts, S.A. (2013) Severe Clostridium difficile infection in New Zealand associated with an emerging strain, PCR-ribotype 244. New Zealand Medical Journal, 126 (1380). pp. 9-14.

Blackwood, B., Thompson, G., McMullan, R., Stevenson, M., Riley, T.V., Alderdice, F.A., Trinder, T.J., Lavery, G.G. and McAuley, D.F. (2013) Tea tree oil (5%) body wash versus standard care (Johnson's Baby Softwash) to prevent colonization with methicillin-resistant Staphylococcus aureus in critically ill adults: a randomized controlled trial. Journal of Antimicrobial Chemotherapy, 68 (5). pp. 1193-1199.

Aravena-Roman, M., Inglis, T.J J., Henderson, B., Riley, T.V. and Chang, B.J. (2012) Antimicrobial susceptibilities of Aeromonas strains isolated from clinical and environmental sources to 26 antimicrobial agents. Antimicrobial agents and chemotherapy, 56 (2). pp. 1110-1112.

Sun, W., Jacoby, P., Riley, T.V., Bowman, J., Leach, A.J., Coates, H., Weeks, S., Cripps, A. and Lehmann, D. (2012) Association between early bacterial carriage and otitis media in Aboriginal and non-Aboriginal children in a semi-arid area of Western Australia: a cohort study. BMC Infectious Diseases, 12 (1).

Sudjana, A.N., Carson, C.F., Carson, K.C., Riley, T.V. and Hammer, K.A. (2012) Candida albicans adhesion to human epithelial cells and polystyrene and formation of biofilm is reduced by sub-inhibitory Melaleuca alternifolia (tea tree) essential oil. Medical Mycology, 50 (8). pp. 863-870.

Hensgens, M.P.M., Keessen, E.C., Squire, M.M., Riley, T.V., Koene, M.G.J., de Boer, E., Lipman, L.J.A. and Kuijper, E.J. (2012) Clostridium difficile infection in the community: a zoonotic disease? Clinical Microbiology and Infection, 18 (7). pp. 635-645.

He, M., Miyajima, F., Roberts, P., Ellison, L., Pickard, D.J., Martin, M.J., Connor, T.R., Harris, S.R., Fairley, D., Bamford, K.B., D'Arc, S., Brazier, J., Brown, D., Coia, J.E., Douce, G.l, Gerding, D., Kim, H.J., Koh, T.H., Kato, H., Senoh, M., Louie, T., Michell, S., Butt, E., Peacock, S.J., Brown, N.M., Riley, T., Songer, G., Wilcox, M., Pirmohamed, M., Kuijper, E., Hawkey, P.r, Wren, B.W., Dougan, G., Parkhill, J. and Lawley, T.D. (2012) Emergence and global spread of epidemic healthcare-associated Clostridium difficile. Nature Genetics, 45 (1). pp. 109-113.

Foster, N.F. and Riley, T.V. (2012) Improved recovery of Clostridium difficile spores with the incorporation of synthetic taurocholate in cycloserine-cefoxitin-fructose agar (CCFA). Pathology, 44 (4). pp. 354-356.

Hutton, P.G., Durmic, Z., Ghisalberti, E.L., Flematti, G.R., Duncan, R.M., Carson, C.F., Riley, T.V. and Vercoe, P.E. (2012) Inhibition of ruminal bacteria involved in lactic acid metabolism by extracts from Australian plants. Animal Feed Science and Technology, 176 (1-4). pp. 170-177.

Ahmed, N., Stabler, R.A., Dawson, L.F., Valiente, E., Cairns, M.D., Martin, M.J., Donahue, E.H., Riley, T.V., Songer, J.G., Kuijper, E.J., Dingle, K.E. and Wren, B.W. (2012) Macro and micro diversity of Clostridium difficile isolates from diverse sources and geographical locations. PLoS ONE, 7 (3). e31559.

Sathyendran, V., Riley, T.V., Roberts, S.A. and Freeman, J.T. (2012) Mycotic abdominal aortic aneurysm caused by toxigenic Clostridium difficile. Anaerobe, 18 (3). pp. 270-272.

Verwer, P.E.B., Robinson, J.O., Coombs, G.W., Wijesuriya, T., Murray, R.J., Verbrugh, H.A., Riley, T., Nouwen, J.L. and Christiansen, K.J. (2012) Prevalence of nasal methicillin-resistant Staphylococcus aureus colonization in healthcare workers in a Western Australian acute care hospital. European Journal of Clinical Microbiology & Infectious Diseases, 31 (6). pp. 1067-1072.

Ireland, D.J., Greay, S.J., Hooper, C.M., Kissick, H.T., Filion, P., Riley, T.V. and Beilharz, M.W. (2012) Topically applied Melaleuca alternifolia (tea tree) oil causes direct anti-cancer cytotoxicity in subcutaneous tumour bearing mice. Journal of Dermatological Science, 67 (2). pp. 120-129.

Carson, C.F., Hammer, K.A., Southwell, I.A. and Riley, T.V. (2012) [The side effects are exaggerated]. [Biverkningarna är överdrivna.]. Läkartidningen, 109 (32-33). p. 1419.

Cheng, A.C., Ferguson, J.K., Richards, M.J., Robson, J.M., Gilbert, G.L., McGregor, A., Roberts, S., Korman, T.M. and Riley, T.V. (2011) Australasian Society for Infectious Diseases guidelines for the diagnosis and treatment of Clostridium difficile infection. Medical Journal of Australia, 194 (7). pp. 353-358.

Richards, M., Knox, J., Elliott, B., Mackin, K., Lyras, D., Waring, L.J. and Riley, T.V. (2011) Severe infection with Clostridium difficile PCR ribotype 027 acquired in Melbourne, Australia. Medical Journal of Australia, 194 (7). pp. 369-371.

Aravena-Roman, M., Harnett, G.B., Riley, T.V., Inglis, T.J.J. and Chang, B.J. (2011) Aeromonas aquariorum is widely distributed in clinical and environmental specimens and can be misidentified as Aeromonas hydrophila. Journal of Clinical Microbiology, 49 (8). pp. 3006-3008.

Thean, S., Elliott, B. and Riley, T.V. (2011) Clostridium difficile in horses in Australia - a preliminary study. Journal of Medical Microbiology, 60 (8). pp. 1188-1192.

Ferguson, J.K., Cheng, A.C., Gilbert, G. L., Gottlieb, T., Korman, T., Mcgregor, A., Richards, M., Roberts, S., Robson, J., Gessel, H.V. and Riley, T.V. (2011) Clostridium difficile laboratory testing in Australia and New Zealand: national survey results and Australasian Society for Infectious Diseases recommendations for best practice. Pathology, 43 (5). pp. 482-487.

Jacoby, P., Carville, K.S., Hall, G., Riley, T.V., Bowman, J., Leach, A.J. and Lehmann, D. (2011) Crowding and other strong predictors of upper respiratory tract carriage of otitis media-related bacteria in Australian aboriginal and non-aboriginal Children. The Pediatric Infectious Disease Journal, 30 (6). pp. 480-485.

Elliott, B., Squire, M.M., Thean, S., Chang, B.J., Brazier, J.S., Rupnik, M. and Riley, T.V. (2011) New types of toxin A-negative, toxin B-positive strains among clinical isolates of Clostridium difficile in Australia. Journal of Medical Microbiology, 60 (8). pp. 1108-1111.

Aravena-Roman, M., Chang, B.J., Riley, T.V. and Inglis, T.J.J. (2011) Phenotypic characteristics of human clinical and environmental Aeromonas in Western Australia. Pathology, 43 (4). pp. 350-356.

Aravena-Roman, M., Chang, B.J., Riley, T.V. and Inglis, T.J.J. (2011) Phenotypic characteristics of human clinical and environmental Aeromonas in Western Australia. Pathology, 43 (4). pp. 350-356.

Wiertsema, S.P., Kirkham, L-A.S., Corscadden, K.J., Mowe, E.N., Bowman, J.M., Jacoby, P., Francis, R., Vijayasekaran, S., Coates, H.L., Riley, T.V. and Richmond, P. (2011) Predominance of nontypeable Haemophilus influenzae in children with otitis media following introduction of a 3+0 pneumococcal conjugate vaccine schedule. Vaccine, 29 (32). pp. 5163-5170.

Thomsen, P.S., Jensen, T.M., Hammer, K.A., Carson, C.F., Mølgaard, Per and Riley, T.V. (2011) Survey of the antimicrobial activity of commercially available Australian tea tree (Melaleuca alternifolia) essential oil products in vitro. The Journal of Alternative and Complementary Medicine, 17 (9). pp. 835-841.

Edmondson, M., Newall, N., Carville, K., Smith, J., Riley, T.V. and Carson, C.F. (2011) Uncontrolled, open-label, pilot study of tea tree (Melaleuca alternifolia) oil solution in the decolonisation of methicillin-resistant Staphylococcus aureus positive wounds and its influence on wound healing. International Wound Journal, 8 (4). pp. 375-384.

Lengkeek, N.A., Boulos, R.A., McKinley, A.J., Riley, T.V., Martinac, B. and Stewart, S.G. (2011) The synthesis of fluorescent DNA intercalator precursors through efficient multiple heck reactions. Australian Journal of Chemistry, 64 (3). p. 316.

Pingault, N.M., Bowman, J.M., Lehmann, D. and Riley, T.V. (2010) Antimicrobial susceptibility of Moraxella catarrhalis isolated from children in Kalgoorlie–Boulder, Western Australia. Pathology, 42 (3). pp. 273-279.

Clements, A.C.A., Magalhaes, R.J.S., Tatem, A.J., Paterson, D.L. and Riley, T.V. (2010) Clostridium difficile PCR ribotype 027: assessing the risks of further worldwide spread. The Lancet Infectious Diseases, 10 (6). pp. 395-404.

Wang, Q., Chang, B.J. and Riley, T.V. (2010) Erysipelothrix rhusiopathiae. Veterinary Microbiology, 140 (3-4). pp. 405-417.

Riley, T.V. (2010) From obscurity to ‘superbug’ – The rise of Clostridium difficile. Healthcare infection, 15 (3). pp. 59-61.

Greay, S.J., Ireland, D.J., Kissick, H.T., Levy, A., Beilharz, M.W., Riley, T.V. and Carson, C.F. (2010) Induction of necrosis and cell cycle arrest in murine cancer cell lines by Melaleuca alternifolia (tea tree) oil and terpinen-4-ol. Cancer Chemotherapy and Pharmacology, 65 (5). pp. 877-888.

Greay, S.J., Ireland, D.J., Kissick, H.T., Heenan, P.J., Carson, C.F., Riley, T.V. and Beilharz, M.W. (2010) Inhibition of established subcutaneous murine tumour growth with topical Melaleuca alternifolia (tea tree) oil. Cancer Chemotherapy and Pharmacology, 66 (6). pp. 1095-1102.

Moorin, R.E., Heyworth, J.S., Forbes, G.M. and Riley, T.V. (2010) Long-term health risks for children and young adults after infective gastroenteritis. Emerging Infectious Diseases, 16 (9). pp. 1440-1447.

Kirkham, L.-A.S., Wiertsema, S.P., Mowe, E.N., Bowman, J.M., Riley, T.V. and Richmond, P.C. (2010) Nasopharyngeal carriage of Haemophilus haemolyticus in otitis-prone and healthy children. Journal of Clinical Microbiology, 48 (7). pp. 2557-2559.

Moore, H.C., Jacoby, P., Taylor, A., Harnett, G., Bowman, J., Riley, T.V., Reuter, K., Smith, D.W. and Lehmann, D. (2010) The interaction between respiratory viruses and pathogenic bacteria in the upper respiratory tract of asymptomatic aboriginal and non-aboriginal children. The Pediatric Infectious Disease Journal, 29 (6). pp. 540-545.

Riley, T.V., Thean, S., Hool, G. and Golledge, C.L. (2009) First Australian isolation of epidemic Clostridium difficile PCR ribotype 027. Medical Journal of Australia, 190 (12). pp. 706-708.

Sudjana, A.N., D’Orazio, C., Ryan, V., Rasool, N., Ng, J., Islam, N., Riley, T.V. and Hammer, K.A. (2009) Antimicrobial activity of commercial Olea europaea (olive) leaf extract. International Journal of Antimicrobial Agents, 33 (5). pp. 461-463.

Elliott, B., Reed, R., Chang, B.J. and Riley, T.V. (2009) Bacteremia with a large clostridial toxin-negative, binary toxin-positive strain of Clostridium difficile. Anaerobe, 15 (6). pp. 249-251.

Chailertvanitkul, P., Abbott, P.V., Riley, T.V. and Sooksuntisakoonchai, N. (2009) Bacterial and dye penetration through interim restorations used during endodontic treatment of molar teeth. Journal of Endodontics, 35 (7). pp. 1017-1022.

Van Gessel, H., Riley, T.V. and McGregor, A. (2009) Clostridium difficile infection: an update for infection control practitioners. Healthcare infection, 14 (3). pp. 115-118.

Lehmann, D., Weeks, S., Jacoby, P., Elsbury, D., Finucane, J., Stokes, A., Monck, R., Coates, H., Aalberse, J., Alpers, K., Arumugaswamy, A., Beissbarth, J., Bonney, P., Bowman, J., Carter, J., Carville, K., Coleman, S., Cripps, A., Dorizzi, L., Dunn, D., Edwards, E., Forrest, A., Foxwell, R., Gordon, C., Harrington, B., Harnett, G., Jeffries-Stokes, C., Johnston, J., Jones, G., de Klerk, N.H., Kyd, J., Kyaw-Myint, S.M., Lannigan, F., Leach, A.J., Lewis, T., McAullay, D., McIntosh, P., Meiklejohn, K., Murphy, D., Nichols, F., Pingault, N., Richmond, P., Riley, T.V., Sivwright, K., Smith, D., Sorian, S., Spencer, J., Stanley, F.J., Tamwoy, J., Taylor, A., Watson, K. and Wood, K. (2008) Absent otoacoustic emissions predict otitis media in young Aboriginal children: A birth cohort study in Aboriginal and non-Aboriginal children in an arid zone of Western Australia. BMC Pediatrics, 8 (1). Article number 32.

Ingarfield, S.L., Celenza, A., Jacobs, I.G. and Riley, T.V. (2008) Acute upper respiratory infections in Western Australian emergency departments, 2000–2003. Australian Health Review, 32 (4). pp. 691-699.

Carson, C.F. and Riley, T.V. (2008) Antimicrobial activity of the major components of the essential oil of Melaleuca alternifolia. Journal of Applied Bacteriology, 78 (3). pp. 264-269.

Hammer, K.A., Carson, C.F., Dunstan, J.A., Hale, J., Lehmann, H., Robinson, C.J., Prescott, S.L. and Riley, T.V. (2008) Antimicrobial and anti-inflammatory activity of fiveTaxandria fragransoilsin vitro. Microbiology and Immunology, 52 (11). pp. 522-530.

Foster, N.F., Harnett, G.B., Riley, T.V. and Chang, B.J. (2008) Cross-Reaction of Stenotrophomonas and Xanthomonas Species in a 23S rRNA Gene-Directed PCR for Detection of S. maltophilia. Journal of Clinical Microbiology, 46 (12). pp. 4111-4113.

Foster, N.F., Chang, B.J. and Riley, T.V. (2008) Evaluation of a modified selective differential medium for the isolation of Stenotrophomonas maltophilia. Journal of Microbiological Methods, 75 (1). pp. 153-155.

Hammer, K.A., Carson, C.F. and Riley, T.V. (2008) Frequencies of resistance to Melaleuca alternifolia (tea tree) oil and rifampicin in Staphylococcus aureus, Staphylococcus epidermidis and Enterococcus faecalis. International Journal of Antimicrobial Agents, 32 (2). pp. 170-173.

Pingault, N.M., Lehmann, D. and Riley, T.V. (2008) Improved pulsed field gel electrophoresis method for Moraxella catarrhalis. Journal of Microbiological Methods, 75 (2). pp. 344-345.

Kim, H., Riley, T.V., Kim, M., Kim, C.K., Yong, D., Lee, K., Chong, Y. and Park, J.-W. (2008) Increasing prevalence of toxin A-negative, Toxin B-positive isolates of Clostridium difficile in Korea: Impact on laboratory diagnosis. Journal of Clinical Microbiology, 46 (3). pp. 1116-1117.

Papadopoulos, C.J., Carson, C.F., Chang, B.J. and Riley, T.V. (2008) Role of the MexAB-OprM Efflux Pump of Pseudomonas aeruginosa in tolerance to tea tree (Melaleuca alternifolia) oil and its monoterpene components terpinen-4-ol, 1,8-Cineole, and α-Terpineol ∇. Applied and Environmental Microbiology, 74 (6). pp. 1932-1935.

Carson, C.F., Smith, D.W., Lampacher, G.J. and Riley, T.V. (2008) Use of deception to achieve double-blinding in a clinical trial of Melaleuca alternifolia (tea tree) oil for the treatment of recurrent herpes labialis. Contemporary Clinical Trials, 29 (1). pp. 9-12.

Riley, T.V. (2008) A note on hydrolysis of tributyrin by Branhamella and Neisseria. Journal of Applied Bacteriology, 62 (6). pp. 539-542.

Riley, T.V. and Taylor, M.L. (2008) A note on susceptibility of Branhamella catarrhalis to heavy metals. Journal of Applied Bacteriology, 67 (2). pp. 185-189.

Elliott, B., Chang, B.J., Golledge, C.L. and Riley, T.V. (2007) Clostridium difficile-associated diarrhoea. Internal Medicine Journal, 37 (8). pp. 561-568.

Carville, K.S., Bowman, J.M., Lehmann, D. and Riley, T.V. (2007) Comparison between nasal swabs and nasopharyngeal aspirates for, and effect of time in transit on, isolation of Streptococcus pneumoniae, Staphylococcus aureus, Haemophilus influenzae, and Moraxella catarrhalis. Journal of Clinical Microbiology, 45 (1). pp. 244-245.

van de Sande, W.W.J., Fahal, A.H., Riley, T.V., Verbrugh, H. and van Belkum, A. (2007) In vitro susceptibility of Madurella mycetomatis, prime agent of Madura foot, to tea tree oil and artemisinin. Journal of Antimicrobial Chemotherapy, 59 (3). pp. 553-555.

Carson, K.C., Bartlett, J.G., Tan, T.-J. and Riley, T.V. (2007) In vitro susceptibility of methicillin-resistant Staphylococcus aureus and methicillin-susceptible Staphylococcus aureus to a new antimicrobial, copper silicate. Antimicrobial Agents and Chemotherapy, 51 (12). pp. 4505-4507.

Jacoby, P., Watson, K., Bowman, J., Taylor, A., Riley, T.V., Smith, D.W. and Lehmann, D. (2007) Modelling the co-occurrence of Streptococcus pneumoniae with other bacterial and viral pathogens in the upper respiratory tract. Vaccine, 25 (13). pp. 2458-2464.

Ingarfield, S.L., Celenza, A., Jacobs, I.G. and Riley, T.V. (2007) Outcomes in patients with an emergency department diagnosis of fever of unknown origin. Emergency Medicine Australasia, 19 (2). pp. 105-112.

Ingarfield, S.L., Celenza, A., Jacobs, I.G. and Riley, T.V. (2007) The bacteriology of pneumonia diagnosed in Western Australian emergency departments. Epidemiology and Infection, 135 (08). pp. 1376-1383.

Pingault, N.M., Lehmann, D., Bowman, J. and Riley, T.V. (2007) A comparison of molecular typing methods for Moraxella catarrhalis. Journal of Applied Microbiology, 103 (6). pp. 2489-2495.

Brooke, C.J., Riley, T.V. and Hampson, D.J. (2006) Comparison of prevalence and risk factors for faecal carriage of the intestinal spirochaetes Brachyspira aalborgi and Brachyspira pilosicoli in four Australian populations. Epidemiology and Infection, 134 (03). pp. 627-634.

Carson, C.F., Hammer, K.A. and Riley, T.V. (2006) Melaleuca alternifolia (tea tree) oil: A review of antimicrobial and other medicinal properties. Clinical Microbiology Reviews, 19 (1). pp. 50-62.

Papadopoulos, C.J., Carson, C.F., Hammer, K.A. and Riley, T.V. (2006) Susceptibility of pseudomonads to Melaleuca alternifolia (tea tree) oil and components. Journal of Antimicrobial Chemotherapy, 58 (2). pp. 449-451.

Watson, K., Carville, K., Bowman, J., Jacoby, P., Riley, T.V., Leach, A.J. and Lehmann, D. (2006) Upper respiratory tract bacterial carriage in Aboriginal and non-Aboriginal children in a semi-arid area of Western Australia. The Pediatric Infectious Disease Journal, 25 (9). pp. 782-790.

Hammer, K.A., Carson, C.F., Riley, T.V. and Nielsen, J.B. (2006) A review of the toxicity of Melaleuca alternifolia (tea tree) oil. Food and Chemical Toxicology, 44 (5). pp. 616-625.

Messager, S., Hammer, K.A., Carson, C.F. and Riley, T.V. (2005) Assessment of the antibacterial activity of tea tree oil using the European EN 1276 and EN 12054 standard suspension tests. Journal of Hospital Infection, 59 (2). pp. 113-125.

Pirson, M., Dramaix, M., Struelens, M., Riley, T.V. and Leclercq, P. (2005) Costs associated with hospital-acquired bacteraemia in a Belgian hospital. Journal of Hospital Infection, 59 (1). pp. 33-40.

Goh, S., Chang, B.J. and Riley, T.V. (2005) Effect of phage infection on toxin production by Clostridium difficile. Journal of Medical Microbiology, 54 (2). pp. 129-135.

Messager, S., Hammer, K.A., Carson, C.F. and Riley, T.V. (2005) Effectiveness of hand-cleansing formulations containing tea tree oil assessed ex vivo on human skin and in vivo with volunteers using European standard EN 1499. Journal of Hospital Infection, 59 (3). pp. 220-228.

Goh, S., Riley, T.V. and Chang, B.J. (2005) Isolation and characterization of temperate bacteriophages of Clostridium difficile. Applied and Environmental Microbiology, 71 (2). pp. 1079-1083.

Dailey, L., Coombs, G.W., O'Brien, F.G., Pearman, J.W., Christiansen, K., Grubb, W.B. and Riley, T.V. (2005) Methicillin-resistant Staphylococcus aureus, Western Australia. Emerging Infectious Diseases, 11 (10). pp. 1584-1590.

Hammer, K.A., Carson, C.F. and Riley, T.V. (2005) Nature's antiseptic. INFORM - International News of Fats, Oils and Related Materials, 16 (9). pp. 546-547.

Wang, Q., Chang, B.J., Mee, B.J. and Riley, T.V. (2005) Neuraminidase production by Erysipelothrix rhusiopathiae. Veterinary Microbiology, 107 (3-4). pp. 265-272.

Hammer, K.A., Carson, C.F. and Riley, T.V. (2004) Antifungal effects of Melaleuca alternifolia (tea tree) oil and its components on Candida albicans, Candida glabrata and Saccharomyces cerevisiae. Journal of Antimicrobial Chemotherapy, 53 (6). pp. 1081-1085.

Cordova, S.P, Heath, C.H, McGechie, D.B, Keil, A.D, Beers, M.Y and Riley, T.V. (2004) Methicillin-resistant Staphylococcus aureus bacteraemia in Western Australian teaching hospitals, 1997–1999: risk factors, outcomes and implications for management. Journal of Hospital Infection, 56 (1). pp. 22-28.

Riley, T.V. (2004) Nosocomial diarrhoea due to Clostridium difficile. Current Opinion in Infectious Diseases, 17 (4). pp. 323-327.

Thomas, C, Cadwallader, H.L and Riley, T.V. (2004) Surgical-site infections after orthopaedic surgery: statewide surveillance using linked administrative databases. Journal of Hospital Infection, 57 (1). pp. 25-30.

Longbottom, C.J., Carson, C.F., Hammer, K.A., Mee, B.J. and Riley, T.V. (2004) Tolerance of Pseudomonas aeruginosa to Melaleuca alternifolia (tea tree) oil is associated with the outer membrane and energy-dependent cellular processes. Journal of Antimicrobial Chemotherapy, 54 (2). pp. 386-392.

Unicomb, L., Ferguson, J., Riley, T.V. and Collignon, P. (2003) Fluoroquinolone resistance in Campylobacter absent from isolates, Australia. Emerging infectious diseases, 9 (11). pp. 1482-1483.

Thomas, C., Stevenson, M. and Riley, T.V. (2003) Antibiotics and hospital-acquired Clostridium difficile-associated diarrhoea: A systematic review. Journal of Antimicrobial Chemotherapy, 51 (6). pp. 1339-1350.

Hammer, K.A., Carson, C.F. and Riley, T.V. (2003) Antifungal activity of the components of Melaleuca alternifolia (tea tree) oil. Journal of Applied Microbiology, 95 (4). pp. 853-860.

Brooke, C.J., Riley, T.V. and Hampson, D.J. (2003) Evaluation of selective media for the isolation of Brachyspira aalborgi from human faeces. Journal of Medical Microbiology, 52 (6). pp. 509-513.

Su, L.-H., Ou, J.T., Leu, H.-S., Chiang, P.-C., Chiu, Y.-P., Chia, J.-H., Kuo, A.-J., Chiu, C.-H., Chu, C., Wu, T.-L., Sun, C.-F., Riley, T.V. and Chang, B.J. (2003) Extended epidemic of nosocomial urinary tract infections caused by Serratia marcescens. Journal of Clinical Microbiology, 41 (10). pp. 4726-4732.

Brooke, C.J., Hampson, D.J. and Riley, T.V. (2003) In vitro antimicrobial susceptibility of Brachyspira pilosicoli isolates from humans. Antimicrobial agents and chemotherapy, 47 (7). pp. 2354-2357.

Hammer, K. A., Dry, L., Johnson, M., Michalak, E. M., Carson, C. F. and Riley, T.V. (2003) Susceptibility of oral bacteria to Melaleuca alternifolia (tea tree) oil in vitro. Oral Microbiology and Immunology, 18 (6). pp. 389-392.

Coles, K.A., Knuiman, M.W., Plant, A.J., Riley, T.V., Smith, D.W. and Divitini, M.L. (2003) A prospective study of infection and cardiovascular diseases: the Busselton Health Study. European Journal of Cardiovascular Prevention & Rehabilitation, 10 (4). pp. 278-282.

Hammer, K.A., Carson, C.F. and Riley, T.V. (2002) In vitro activity of Melaleuca alternifolia (tea tree) oil against dermatophytes and other filamentous fungi. The Journal of antimicrobial chemotherapy, 50 (2). pp. 195-199.

Riley, T.V. (2002) 20 Years of Clostridium difficile-associated diarrhoea - Will it resolve? Australian Journal of Medical Science, 23 (4). pp. 156-161.

Thomas, C., Stevenson, M., Williamson, D.J. and Riley, T.V. (2002) Clostridium difficile–associated diarrhea: Epidemiological data from Western Australia associated with a modified antibiotic policy. Clinical Infectious Diseases, 35 (12). pp. 1457-1462.

Carson, C.F., Mee, B.J. and Riley, T.V. (2002) Mechanism of action of Melaleuca alternifolia (tea tree) oil on Staphylococcus aureus determined by time-kill, lysis, leakage, and salt tolerance assays and electron microscopy. Antimicrobial Agents and Chemotherapy, 46 (6). pp. 1914-1920.

Fidalgo, S.G., Longbottom, C.J. and Riley, T.V. (2002) Susceptibility of Erysipelothrix rhusiopathiae to antimicrobial agents and home disinfectants. Pathology, 34 (5). pp. 462-465.

Wang, Q., Fidalgo, S., Chang, B.J., Mee, B.J. and Riley, T.V. (2002) The detection and recovery of Erysipelothrix spp. in meat and abattoir samples in Western Australia. Journal of Applied Microbiology, 92 (5). pp. 844-850.

Brooke, C.J., Clair, A.N., Mikosza, A.S.J., Riley, T.V. and Hampson, D.J. (2001) Carriage of intestinal spirochaetes by humans: epidemiological data from Western Australia. Epidemiology and Infection, 127 (02). pp. 369-374.

Brooke, C.J., Hampson, D.J., Riley, T. and Lum, G. (2001) Failure to detect Brachyspira pilosicoli in bloodstream of Australian patients. Journal of Clinical Microbiology, 39 (11). p. 4219.

Carson, C.F. and Riley, T.V. (2001) Safety, efficacy and provenance of tea tree (Melaleuca alternifolia) oil. Contact Dermatitis, 45 (2). pp. 65-67.

Caelli, M., Porteous, J., Carson, C.F., Heller, R. and Riley, T.V. (2001) Tea tree oil as an alternative topical decolonization agent for methicillin-resistant Staphylococcus aureus. International Journal of Aromatherapy, 11 (2). pp. 97-99.

Kennon, J., Russo, P., Cadwallader, H.L., Dyson, A. and Riley, T.V. (2001) To disinfect or not to disinfect the foot in total joint arthroplasty of the lower limb. Journal of Hospital Infection, 49 (4). pp. 304-305.

Cadwallader, H.L., Toohey, M., Linton, S., Dyson, A. and Riley, T.V. (2001) A comparison of two methods for identifying surgical site infections following orthopaedic surgery. Journal of Hospital Infection, 48 (4). pp. 261-266.

Brand, C., Ferrante, A., Prager, R.H., Riley, T.V., Carson, C.F., Finlay-Jones, J.J. and Hart, P.H. (2001) The water-soluble components of the essential oil of Melaleuca alternifolia (tea tree oil) suppress the production of superoxide by human monocytes, but not neutrophils, activated in vitro. Inflammation Research, 50 (4). pp. 213-219.

Hammer, K.A., Carson, C.F. and Riley, T.V. (2000) Melaleuca alternifolia (tea tree) oil inhibits germ tube formation by Candida albicans. Medical mycology, 38 (5). pp. 355-362.

Hammer, K.A. and Riley, T.V. (2000) Precipitate production by some Malassezia species on Dixon's agar. Medical mycology, 38 (2). pp. 105-107.

Fidalgo, S.G., Wang, Q. and Riley, T.V. (2000) Comparison of methods for detection of Erysipelothrix spp. and their distribution in some Australasian seafoods. Applied and Environmental Microbiology, 66 (5). pp. 2066-2070.

Brooke, C.J., Margawani, K.R., Pearson, A.K., Riley, T.V., Robertson, I.D. and Hampson, D.J. (2000) Evaluation of blood culture systems for detection of the intestinal spirochaete Brachyspira (Serpulina) pilosicoli in human blood. Journal of Medical Microbiology, 49 (11). pp. 1031-1036.

Hammer, K.A., Carson, C.F. and Riley, T.V. (2000) In vitro activities of ketoconazole, econazole, miconazole, and Melaleuca alternifolia (tea tree) oil against Malassezia species. Antimicrobial Agents and Chemotherapy, 44 (2). pp. 467-469.

Greig, J.E., Carson, C.F., Stuckey, M.S. and Riley, T.V. (2000) Prevalence of delayed hypersensitivity to the European standard series in a self-selected population. Australasian Journal of Dermatology, 41 (2). pp. 86-89.

Caelli, M., Porteous, J., Carson, C.F, Heller, R. and Riley, T.V. (2000) Tea tree oil as an alternative topical decolonization agent for methicillin-resistant Staphylococcus aureus. Journal of Hospital Infection, 46 (3). pp. 236-237.

Hart, P.H., Brand, C., Carson, C.F., Riley, T.V., Prager, R.H. and Finlay-Jones, J.J. (2000) Terpinen-4-ol, the main component of the essential oil of Melaleuca alternifolia (tea tree oil), suppresses inflammatory mediator production by activated human monocytes. Inflammation Research, 49 (11). pp. 619-626.

Grubb, W.B., Pearman, J.W., Gracey, M.S., O'Brien, F.G., Riley, T.V. and Coombs, G.W. (2000) The community strikes back - Antibiotic resistance in the community. Today's Life Science, 12 (3). pp. 26-29.

Greig, J.E., Thoo, S.L., Carson, C.F. and Riley, T.V. (1999) Allergic contact dermatitis following use of a tea tree oil hand-wash not due to tea tree oil. Contact dermatitis, 41 (6). pp. 354-355.

O'Brien, F.G., Pearman, J.W., Gracey, M., Riley, T.V. and Grubb, W.B. (1999) Community strain of methicillin-resistant Staphylococcus aureus involved in a hospital outbreak. Journal of clinical microbiology, 37 (9). pp. 2858-2862.

Brooke, C.J. and Riley, T.V. (1999) Erysipelothrix rhusiopathiae: bacteriology, epidemiology and clinical manifestations of an occupational pathogen. Journal of medical microbiology, 48 (9). pp. 789-799.

Hammer, K.A., Carson, C.F. and Riley, T.V. (1999) Antimicrobial activity of essential oils and other plant extracts. Journal of Applied Microbiology, 86 (6). pp. 985-990.

Hammer, K.A., Carson, C.F. and Riley, T.V. (1999) Influence of organic matter, cations and surfactants on the antimicrobial activity of Melaleuca alternifolia (tea tree) oil in vitro. Journal of Applied Microbiology, 86 (3). pp. 446-452.

Coles, K.A., Plant, A.J., Riley, T.V., Smith, D.W., McQuillan, B.M. and Thompson, P.L. (1999) Lack of association between seropositivity to Chlamydia pneumoniae and carotid atherosclerosis. The American Journal of Cardiology, 84 (7). pp. 825-828.

Chen, F., Chakera, A., Seow, C., Ling, K., Plant, A.J. and Riley, T.V. (1999) More on Clostridium difficile-associated diarrhoea in Australia. Anaerobe, 5 (3-4). pp. 205-207.

Torvaldsen, S., Roberts, C. and Riley, T.V. (1999) The continuing evolution of methicillin-resistant staphylococcus aureus in Western Australia. Infection Control and Hospital Epidemiology, 20 (2). pp. 133-135.

McGregor, K., Chang, B.J., Mee, B.J. and Riley, T.V. (1998) Moraxella catarrhalis: clinical significance, antimicrobial susceptibility and BRO beta-lactamases. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 17 (4). pp. 219-34.

Coles, K.A., Plant, A.J., Riley, T.V. and Smith, D.W. (1998) Cardiovascular disease: An infectious aetiology? Reviews in Medical Microbiology, 9 (1). pp. 17-27.

Carson, C.F., Riley, T.V. and Cookson, B.D. (1998) Efficacy and safety of tea tree oil as a topical antimicrobial agent. Journal of Hospital Infection, 40 (3). pp. 175-178.

Hammer, K.A., Carson, C.F. and Riley, T.V. (1998) In-vitro activity of essential oils, in particular Melaleuca alternifolia (tea tree) oil and tea tree oil products, against Candida spp. Journal of Antimicrobial Chemotherapy, 42 (5). pp. 591-595.

McLaughlin, V.A., Riley, T.V. and Roberts, C.L. (1998) Penicillin resistance in laboratory isolates of Streptococcus pneumoniae, in Western Australia, 1990-1994. European Journal of Epidemiology, 14 (6). pp. 611-615.

Hammer, K.A., Carson, C.F. and Riley, T.V. (1997) In vitro susceptibility of Malassezia furfur to the essential oil of Melaleuca alternifolia. Medical Mycology, 35 (5). pp. 375-377.

Hammer, K.A., Carson, C.F. and Riley, T.V. (1997) In vitro susceptibility of Malassezia furfur to the essential oil of Melaleuca alternifolia. Journal of medical and veterinary mycology : bi-monthly publication of the International Society for Human and Animal Mycology, 35 (5). pp. 375-377.

Riley, T.V. (1997) Susceptibility testing of anaerobic bacteria. Australian Journal of Medical Science, 18 (4). p. 142.

Riley, T.V., Webb, S.A.R., Cadwallader, H., Briggs, B.D., Christiansen, L. and Bowman, R.A. (1996) Outbreak of gentamicin-resistant Acinetobacter baumanii in an intensive care unit: clinical, epidemiological and microbiological features. Pathology, 28 (4). pp. 359-363.

Schneider, P.F. and Riley, T.V. (1996) Staphylococcus saprophyticus urinary tract infections: epidemiological data from Western Australia. European Journal of Epidemiology, 12 (1). pp. 51-54.

Hammer, K.A., Carson, C.F. and Riley, T.V. (1996) Susceptibility of transient and commensal skin flora to the essential oil of Melaleuca alternifolia (tea tree oil). American Journal of Infection Control, 24 (3). pp. 186-189.

Riley, T.V., Cooper, M., Bell, B. and Golledge, C.L. (1995) Community-acquired clostridium difficile-associated diarrhea. Clinical Infectious Diseases, 20 (Supplement 2). S263-S265.

Riley, T.V. and Rouse, I.L. (1995) Methicillin-resistant Staphylococcus aureus in Western Australia, 1983–1992. Journal of Hospital Infection, 29 (3). pp. 177-188.

Carson, C.F., Cookson, B.D., Farrelly, H.D. and Riley, T.V. (1995) Susceptibility of methicillin-resistant staphylococcus aureus to the essential oil of melaleuca alternifolia. Journal of Antimicrobial Chemotherapy, 35 (3). pp. 421-424.

Riley, T.V., Bowman, R.A., Golledge, C.L., Humphreys, H., Bordello, S.P. and Payne, G. (1995) Usefulness of culture in the diagnosis of Clostridium difficile infection. European Journal of Clinical Microbiology & Infectious Diseases, 14 (12). pp. 1109-1111.

Riley, T.V., O'Neill, G.L., Bowman, R.A. and Golledge, C.L. (1994) Clostridium difficile-associated diarrhoea: Epidemiological data from Western Australia. Epidemiology and Infection, 113 (01). pp. 13-20.

Lindsay, J.A., Riley, T.V. and Mee, B.J. (1994) Production of siderophore by coagulase-negative staphylococci and its relation to virulence. European Journal of Clinical Microbiology & Infectious Diseases, 13 (12). pp. 1063-1066.

Carson, C.F. and Riley, T.V. (1993) Antimicrobial activity of the essential oil of Melaleuca alternifolia. Letters in Applied Microbiology, 16 (2). pp. 49-55.

Lindsay, J.A., Aravena-Román, M.A. and Riley, T.V. (1993) Identification of Staphylococcus epidermidis and Staphylococcus hominis from blood cultures by testing susceptibility to desferrioxamine. European Journal of Clinical Microbiology & Infectious Diseases, 12 (2). pp. 127-131.

O'Neill, G., Adams, J.E., Bowman, R.A. and Riley, T.V. (1993) A molecular characterization of Clostridium difficile isolates from humans, animals and their environments. Epidemiology and Infection, 111 (02). pp. 257-264.

Golledge, C.L., Carson, C.F., O'Neill, G.L., Bowman, R.A. and Riley, T.V. (1992) Ciprofloxacin and clostridium difficile-associated diarrhoea. Journal of Antimicrobial Chemotherapy, 30 (2). pp. 141-147.

Riley, T.V. and Schneider, P.F. (1992) Infrequency of slime production by urinary isolates of Staphylococcus saprophyticus. Journal of Infection, 24 (1). pp. 63-66.

Schneider, P.F. and Riley, T.V. (1991) Cell-surface hydrophobicity of Staphylococcus saprophyticus. Epidemiology and Infection, 106 (01). pp. 71-75.

Riley, T.V., Adams, J.E., O'Neill, G.L. and Bowman, R.A. (1991) Gastrointestinal carriage of Clostridium difficile in cats and dogs attending veterinary clinics. Epidemiology and Infection, 107 (03). pp. 659-665.

O'Neill, G.L., Beaman, M.H. and Riley, T.V. (1991) Relapse versus reinfection with Clostridium difficile. Epidemiology and Infection, 107 (03). pp. 627-635.

Golledge, C.L., McKenzie, T. and Riley, T.V. (1989) Extended spectrum cephalosporins and Clostridium difficile. Journal of Antimicrobial Chemotherapy, 23 (6). pp. 929-931.

Riley, T.V. (1988) Antimicrobial resistance in Branhamella catarrhalis. Journal of Antimicrobial Chemotherapy, 21 (2). pp. 147-150.

Bowman, R.A. and Riley, T.V. (1988) Laboratory diagnosis of Clostridium difficile-associated diarrhoea. European Journal of Clinical Microbiology & Infectious Diseases, 7 (4). pp. 476-484.

Riley, T.V., Brazier, J.S., Hassan, H., Williams, K. and Phillips, K.D. (1987) Comparison of alcohol shock enrichment and selective enrichment for the isolation of Clostridium difficile. Epidemiology and Infection, 99 (02). pp. 355-359.

Digiovanni, C., Riley, T.V., Hoyne, G.F., Yeo, R. and Cooksey, P. (1987) Respiratory tract infections due to Branhamella catarrhalis: epidemiological data from Western Australia. Epidemiology and Infection, 99 (02). pp. 445-453.

Riley, T.V., Digiovanni, C. and Hoyne, G.F. (1987) Susceptibility of Branhamella catarrhalis to sulphamethoxazole and trimethoprim. Journal of Antimicrobial Chemotherapy, 19 (1). pp. 39-43.

Riley, T.V. (1987) A simple method for detecting heparinase-producing bacteria. Letters in Applied Microbiology, 4 (1). pp. 21-23.

Riley, T.V., Wymer, V., Bamford, V.W. and Bowman, R.A. (1986) Clostridium difficile in general practice and community health. Journal of Hygiene, 96 (01). pp. 13-17.

Riley, T.V. (1986) Interference with Haemophilus influenzae growth by other microorganisms. FEMS Microbiology Letters, 33 (1). pp. 55-58.

Bowman, R.A. and Riley, T.V. (1984) Routine culturing for clostridium difficile? Pathology, 16 (3). pp. 240-242.

Riley, T.V. and Ott, A.K. (1981) Brain abscess due to Arachnia propionica. BMJ, 282 (6269). p. 1035.

Non-refereed Article

Ngamskulrungroj, P., Sanmee, S., Putsathit, P., Piewngam, P., Elliott, B., Riley, T.V. and Kiratisin, P. (2015) Correction: Molecular epidemiology of clostridium difficile infection in a large teaching hospital in Thailand. PLoS ONE, 10 (7). e0134771.

Book Chapter

Wang, Q. and Riley, T.V. (2015) Erysipelothrix rhusiopathiae. In: Tang, Y-W, Sussman, M., Liu, D., Poxton, I. and Schwartzman, J., (eds.) Molecular Medical Microbiology. Academic Press, London, UK, pp. 859-872.

Squire, M.M. and Riley, T.V. (2012) Clostridium difficile infection in humans and piglets: A 'one health' opportunity. In: Mackenzie, J.S., Jeggo, M., Daszak, P. and Richt, J.A., (eds.) One Health: The Human-Animal-Environment Interfaces in Emerging Infectious Diseases. Springer, Heidelberg, pp. 299-314.

López-Lozano, J.-M., Monnet, D.L., Alonso, P.C., Quintero, A.C., Jiménez, N.G., Muñoz, A.Y., Thomas, C., Beyaert, A., Stevenson, M. and Riley, T.V. (2005) Applications of time-series analysis to antibiotic resistance and consumption data. In: Gould, I.M. and van der Meer, J.W.M., (eds.) Antibiotic Policies : Theory and Practice. Springer US, New York, pp. 447-463.

Fidalgo, S.G. and Riley, T.V. (2004) Detection of Erysipelothrix rhusiopathiae in clinical and environmental samples. In: Spencer, J.F.T. and Ragout de Spencer, A.L., (eds.) Public Health Microbiology. Humana Press, pp. 199-205.

Others

Riley, T.V. (2009) Is Clostridium difficile a threat to Australia's biosecurity? Medical Journal of Australia, 190 (12). pp. 661-2.

Riley, T.V. and Huovinen, P. (2008) Introduction. Clinical Microbiology and Infection, 14 (Supplement 5). p. 1.

Riley, T.V. (2006) Epidemic Clostridium difficile. Medical Journal of Australia, 185 (3). pp. 133-134.

Thomas, C., Golledge, C.L. and Riley, T.V. (2002) Ciprofloxacin and Clostridium difficile-associated diarrhea. Infection control and hospital epidemiology, 23 (11). pp. 637-638.

Golledge, C.L. and Riley, T.V. (2001) The efficacy of an antibiotic protocol for community-acquired pneumonia. Medical Journal of Australia, 175 (8). pp. 445-446.

Carson, C.F., Ashton, L., Dry, L., Smith, D.W. and Riley, T.V. (2001) Melaleuca alternifolia (tea tree) oil gel (6%) for the treatment of recurrent herpes labialis. The Journal of antimicrobial chemotherapy, 48 (3). pp. 450-1.

Brooke, C.J., McLaughlin, V., Mee, B.J. and Riley, T.V. (1999) An investigation of "crayfish poisoning" in Western Australia. Medical Journal of Australia, 170 (6). p. 288.

Hammer, K.A., Carson, C.F. and Riley, T.V. (1999) In vitro susceptibilities of lactobacilli and organisms associated with bacterial vaginosis to Melaleuca alternifolia (tea tree) oil. Antimicrobial agents and chemotherapy, 43 (1). p. 196.

Riley, T.V. (1998) Clostridium difficile: a pathogen of the nineties. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 17 (3). pp. 137-41.

Carson, C.F., Hammer, K.A. and Riley, T.V. (1996) In-vitro activity of the essential oil of Melaleuca alternifolia against Streptococcus spp. Journal of Antimicrobial Chemotherapy, 37 (6). pp. 1177-1178.

Riley, T.V. and Aravena, M.A. (1995) Anaerobic bacteraemia in an Australian teaching hospital. European Journal of Clinical Microbiology & Infectious Diseases, 14 (1). pp. 73-75.

Riley, T.V. and Golledge, C.L. (1995) Clindamycin and pseudomembranous colitis. The Lancet, 346 (8975). p. 639.

Golledge, C.L. and Riley, T.V. (1995) Clostridium difficile-associated diarrhoea after doxycycline malaria prophylaxis. The Lancet, 345 (8961). pp. 1377-1378.

Riley, T.V., Codde, J.P. and Rouse, I.L. (1995) Increased length of hospital stay due to Clostridium difficile associated diarrhoea. The Lancet, 345 (8947). pp. 455-456.

Condon, R.J., Riley, T.V. and Kelly, H. (1994) Invasive meningococcal infection after splenectomy. BMJ, 308 (6931). pp. 792-93.

Brazier, J.S., Delmee, M., Tabaqchali, S., Hill, L.R., Mulligan, M.E. and Riley, T.V. (1994) Proposed unified nomenclature for Clostridium difficile typing. The Lancet, 343 (8912). pp. 1578-1579.

Riley, T.V., Bowman, R.A., Carson, C.F. and Golledge, C.L. (1991) Ciprofloxacin and Clostridium difficile-associated diarrhoea. Journal of Infection, 22 (3). pp. 304-305.

O'Keeffe, B.J., Tillotson, G.S., Chew, S.L., Daelemans, R., Lins, R.L., Golledge, C.L., O'Neill, G.L., Carson, C.F., Bowman, R.A., Riley, T.V., Low, N. and Harries, A. (1990) Ciprofloxacin and pseudomembranous colitis. The Lancet, 336 (8729). pp. 1509-1510.

Riley, T.V. and Digiovanni, C. (1989) Susceptibility of branhamella catarrhalis to tetracyclines. Journal of Antimicrobial Chemotherapy, 23 (5). pp. 802-803.

Digiovanni, C. and Riley, T.V. (1987) Three methods for detecting synergy between sulphamethoxazole and trimethoprim against Branhamella catarrhalis. Journal of Antimicrobial Chemotherapy, 19 (4). pp. 553-555.

Riley, T.V. (1985) Clostridium difficile-associated diarrhoea. Journal of Infection, 10 (2). pp. 179-180.

Riley, T.V., Bowman, R.A., Robinson, J. and Burke, V. (1983) Clostridium and difficile and its toxins. The Lancet, 321 (8338). p. 1386.

Hauglustaine, D., Bollens, W., Michielsen, P., Riley, T.V. and Bowman, R.A. (1982) Detection of glomerular bleeding using a simple staining method for light microscopy. The Lancet, 320 (8301). pp. 761-762.

This list was generated on Thu Feb 21 08:35:45 2019 UTC.